Your session is about to expire
← Back to Search
Inspiratory muscle training for Chronic Fatigue Syndrome (Inspire ME Trial)
N/A
Waitlist Available
Led By Heather Edgell, PhD
Research Sponsored by York University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
Inspire ME Trial Summary
This trial will investigate changes in the breathing and cardiovascular responses to stimuli in three groups of participants: 1) healthy control individuals; 2) patients diagnosed with ME/CFS (mild to moderate symptoms); and 3) individuals with previous COVID-19 infection with long-haul symptoms lasting for at least 1 year.
Eligible Conditions
- Chronic Fatigue Syndrome (CFS)
- Post-COVID Syndrome
Inspire ME Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Chemoreflex function
Clinical autonomic function
Cognitive function
+1 moreSecondary outcome measures
Cardiorespiratory fitness
ME symptoms
Inspire ME Trial Design
1Treatment groups
Experimental Treatment
Group I: Inspiratory muscle trainingExperimental Treatment1 Intervention
The 8-week inspiratory muscle training protocol consists of using 80% of maximal inspiratory pressure (determined in lab), 3x per week, 6 sets of 6 repetitions. Each set will be separated by decreasing lengths of time over the 8 weeks starting at a 30 second interim. This totals 36 inhalations 3 times per week. Progress will be determined via weekly phone calls with the participants and progress will also be logged by participants over the 8 weeks.
Find a Location
Who is running the clinical trial?
York UniversityLead Sponsor
59 Previous Clinical Trials
18,073 Total Patients Enrolled
Heather Edgell, PhDPrincipal InvestigatorYork University
Share this study with friends
Copy Link
Messenger